Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: AVP-923 for PBA in ALS/MS
NCT00573443Phase 3Completed
- Sponsor
- Avanir Pharmaceuticals
- Start
- Dec 2007
- Primary completion
- Jun 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dextromethorphan + quinidine in pseudobulbar affect (PBA), sponsored by Avanir Pharmaceuticals. Started Dec 2007; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
pseudobulbar affect (PBA)
Beyond the preview
Go deeper on NCT00573443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573443.